Seminars in Oncology
Volume 36, Issue 3 , Pages 194-206 , June 2009

Cancer in Young Adults 20 to 39 Years of Age: Overview

  • Archie Bleyer

      Affiliations

    • St. Charles Medical Center, Bend, OR; Oregon Health and Science University, Portland, OR; and CureSearch/National Childhood Cancer Foundation, Arcadia, CA
    • Corresponding Author InformationAddress correspondence to Archie Bleyer, MD, 2884 NW Horizon Dr, Bend OR 97701
    • ,
  • Ronald Barr

      Affiliations

    • McMaster Children's Hospital; and Departments of Pediatrics, Pathology and Medicine, McMaster University, Hamilton, Ontario, Canada

References 

  1. Bleyer WA. Adolescents and young adults with cancer: a neglected population (ASCO). In: Educational Book. 2001;p. 125–132
  2. In:  Bleyer WA,  O'Leary M,  Barr R,  Ries LAG editor. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival, 1975-2000. Bethesda, MD: National Cancer Institute; June 2006;NIH Pub. No. 06-5767 www.seer.cancer.gov/publications/aya
  3. In:  Bleyer A,  Barr RD editor. Cancer in adolescents and young adults. New York: Springer Verlag; 2007;
  4. Closing the gap. Research and care imperatives for adolescents and young adults with cancer. Report of the Adolescent and Young Adult Progress Review Group. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute and LiveStrong Young Adult Alliance; http://planning.cancer.gov/disease/AYAO_PRG_Report_2006_FINAL.pdf(accessed October 12, 2008)
  5. http://www.livestrong.org/atf/cf/{D0794917-422C-499C-9C48-9ED3DDC42947}/LAF%20YAA%20Report.pdfaccessed October 12, 2008
  6. http://planning.cancer.gov/disease/AYA-Snapshot.pdfaccessed October 12, 2008
  7. http://www.seer.cancer.gov/csr/1975_2005/results_merged/sect_32_aya_cancer.pdfaccessed October 12, 2008
  8. Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288–298
  9. Bonnet F, Chêne G. Evolving epidemiology of malignancies in HIV. Curr Opin Oncol. 2008;20:534–540
  10. Assessing the burden of HPV-associated cancers in the United States. Cancer. 2008;113(Suppl 10):2837–3057
  11. Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008;113(Suppl 10):2901–2909
  12. Chaturvedi A, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus–related and –unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–619
  13. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23:276–292
  14. Martin S, Ulrich C, Munsell M, et al. Delays in cancer diagnosis in under-insured young adults and older adolescents. Oncologist. 2007;12:816–824
  15. Clemons M, Loijens L, Goss P. Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev. 2000;26:291–302
  16. Verrill MW, Judson IR, Fisher C, et al. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol. 1997;8:1099–1105
  17. Bleyer A, Budd T, Montello M. Lack of clinical trial participation and of progress in older adolescents and young adults with cancer. Curr Probl Pediatr Adolesc Health Care. 2005;35:186–195
  18. Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006;107(Suppl):1645–1655
  19. Bleyer A, Montello M, Budd T, Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer. 2005;103:1891–1897
  20. Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? (A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies). Blood. 2008;112:1646–1654
  21. de Bont JM, van der Holt B, Dekker AW, et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric versus adult ALL protocols in the Netherlands. B. Leukemia. 2004;18:2032–2053
  22. Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? (Comparison of the French FRALLE-93 and LALA-94 trials). J Clin Oncol. 2003;21:774–780
  23. Testi A. Difference in outcome of adolescents (14-17 years) with acute lymphoblastic leukaemia (ALL) enrolled in the Italian pediatric (AIEOP) an adult (GIMEMA) multicenter treatment protocols [abstract]. Proc Am Society Clin Oncol J Clin Oncol. 2006;24(Suppl 18):9024
  24. Ramanujachar R, Richards S, Hann I, Goldstone A, Mitchell C, Vora A, et al Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer. 2007;48:254–261
  25. Ramanujachar R, Richards S, Hann I, et al. Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols. Pediatr Blood Cancer. 2006;43:748–756
  26. Paulussen S, Ahrens S, Juergens HF. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units (Results of GPOH CESS/EICESS studies [abstract]). Proc Am Soc Clin Oncol. 2003;22:816
  27. Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults (A retrospective analysis of 171 patients treated at a single institution). Cancer. 2003;98:571–580
  28. Ferrari A, Montello M, Budd T, et al. The challenges of clinical trial participation for adolescents and young adults with cancer. Pediat Blood Cancer. 2008;50:1101–1104
  29. Ganz PA, Greendale GA, Petersen L, et al. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21:4184–4193
  30. Phillips K-A, Osborne RH, Giles GG, et al. Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study. J Clin Oncol. 2008;26:4666–4671
  31. Yoon J, Malin JL, Tao ML, et al. Symptoms after breast cancer treatment: are they influenced by patient characteristics?. Breast Cancer Res Treat. 2008;108:153–165
  32. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–2931
  33. Roberts JE, Oktay K. Fertility preservation: a comprehensive approach to the young woman with cancer. Natl Cancer Inst Monogr. 2005;34:57–59
  34. Davis M. Fertility considerations for female adolescent and young adult patients following cancer therapy: a guide for counseling patients and their families. Clin J Oncol Nurs. 2006;10:213–219
  35. www.fertilehope.org/learn-more/cancer-and-fertility-info/fertility-risks.cfmAccessed March 29, 2009
  36. Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin. 2007;57:242–255

 Supported in part by a grant from the Aflac Insurance Co to the National Childhood Cancer Foundation.

PII: S0093-7754(09)00038-4

doi: 10.1053/j.seminoncol.2009.03.003

Seminars in Oncology
Volume 36, Issue 3 , Pages 194-206 , June 2009

Article Tools

* Image Usage & Resolution